Cancer Symptom Trials (CST) recognises and celebrates the outstanding achievements and contributions of emerging cancer clinical trial researchers. Nominate an emerging trialist who has excelled in their cancer symptom research during 2024 by 21 February 2025.
CST Emerging Trialist Award 2024
Celia Marston, IMPACCT PhD candidate and CST Emerging Trialist 2023
We are pleased to announce that we are now accepting nominations for the Cancer Symptom Trials Emerging Trialist Award 2024. You can nominate yourself or someone else who meets the criteria below for their work in cancer clinical trials.
The Award will be announced in Sydney on Thursday 27 March at the PaCCSC & CST Research Forum 2025. The winner will receive a certificate and $1000, which can be used for any research-related activity.
Award criteria
You can nominate an emerging cancer clinical trial researcher who:
- has held CST membership for at least 12 months
- has undertaken research into cancer symptoms
- has been a lead or participating investigator in their first or second cancer clinical trial
- is from any health discipline
- is a student, early-career researcher, or mid-career researcher
And who has achieved a significant milestone such as:
- funding received
- ethics approval and site activation
- recruitment - first patient in
- recruitment - reached target
- publication
- presentation - oral and/or poster
Key dates
- Early bird registration open: 15 October 2024
- Abstract submissions open: 15 October 2024
- CST Emerging Trialist Award nominations open: 9 December 2024
- Early bird registrations close: 9 January 2025
- Abstract submissions close: 31 January 2025
- CST Emerging Trialist Award nominations close: 21 February 2025
- Registrations close: 19 March 2025
Click on the button below to submit your nomination by 21 February 2024.
If you have any questions, please email Linda James at cst@uts.edu.au.
https://forms.uts.edu.au/index.cfm?FormId=1551
